Substance use stigma mechanisms associated with greater depressive symptoms, substance use-related problems, and lower behavioral activation

actpapercliniciantier 3link ok

Open source

Overview

AI-generated summary, not a substitute for reading the source.

This cross-sectional study examines the associations between three types of substance use stigma—internalized, enacted, and anticipated—and outcomes such as depressive symptoms, behavioral activation, and substance use-related problems among 212 individuals in methadone treatment. The authors report that internalized stigma was significantly linked to worse outcomes across all domains, while anticipated and enacted stigma showed marginal associations with specific factors. The resource is intended for researchers or clinicians interested in the psychosocial mechanisms of stigma within underserved populations.

ID
7d39af7c724b4d93
Source org
PubMed Central
Author
Morgan S. Anvari (University of Maryland, College Park), Caroline A. Sacko (University of Maryland, College Park), Noah S. Triplett (University of Maryland, College Park), Valerie D. Bradley (University of Maryland, College Park), Mary B. Kleinman (University of Maryland, College Park), Abigail C. Hines (University of Maryland, College Park), Rithika Baskar (University of Maryland, College Park), Jessica S Anane (University of Maryland, College Park), Valerie A. Earnshaw (University of Delaware), Annabelle M. Belcher (University of Maryland, Baltimore), Jessica F. Magidson (University of Maryland, College Park)
Published
2026-05-15
OA status
gold
DOI
10.1016/j.abrep.2026.100705
PMID
Not recorded
PMCID
Not recorded
Citations
0

Tags

Verification

Automated checks only, not clinical endorsement or advice.

Cite this entry

BibTeX

@article{allodium:7d39af7c724b4d93,
  title = {Substance use stigma mechanisms associated with greater depressive symptoms, substance use-related problems, and lower behavioral activation},
  author = {Morgan S. Anvari and Caroline A. Sacko and Noah S. Triplett and Valerie D. Bradley and Mary B. Kleinman and Abigail C. Hines and Rithika Baskar and Jessica S Anane and Valerie A. Earnshaw and Annabelle M. Belcher and Jessica F. Magidson},
  year = {2026},
  journal = {PubMed Central},
  doi = {10.1016/j.abrep.2026.100705},
  url = {https://doi.org/10.1016/j.abrep.2026.100705}
}

RIS

TY  - JOUR
TI  - Substance use stigma mechanisms associated with greater depressive symptoms, substance use-related problems, and lower behavioral activation
AU  - Anvari, Morgan S.
AU  - Sacko, Caroline A.
AU  - Triplett, Noah S.
AU  - Bradley, Valerie D.
AU  - Kleinman, Mary B.
AU  - Hines, Abigail C.
AU  - Baskar, Rithika
AU  - Anane, Jessica S
AU  - Earnshaw, Valerie A.
AU  - Belcher, Annabelle M.
AU  - Magidson, Jessica F.
PY  - 2026
PB  - PubMed Central
DO  - 10.1016/j.abrep.2026.100705
UR  - https://doi.org/10.1016/j.abrep.2026.100705
ER  -

APA

Anvari, M. S., Sacko, C. A., Triplett, N. S., Bradley, V. D., Kleinman, M. B., Hines, A. C., Baskar, R., Anane, J. S., Earnshaw, V. A., Belcher, A. M., & Magidson, J. F. (2026). Substance use stigma mechanisms associated with greater depressive symptoms, substance use-related problems, and lower behavioral activation. PubMed Central. https://doi.org/10.1016/j.abrep.2026.100705

Related entries

More like this